Advertisement

Topics

Companies Related to "Renal artery stenting atherosclerotic renal artery stenosis identified" [Most Relevant Company Matches] [Advanced Search Results] RSS

02:47 EDT 21st September 2018 | BioPortfolio

Here are the most relevant search results for "Renal artery stenting atherosclerotic renal artery stenosis identified" found in our extensive corporate database of over 50,000 company records.

Showing "Renal artery stenting atherosclerotic renal artery stenosis identified" Companies 1–25 of 382

Extremely Relevant

Lutonix, Inc.

Restenosis is the re-narrowing of an artery experienced by some patients following angioplasty, atherectomy, or stenting. Restenosis is caused by an overgrowth of tissue inside the artery wall at the original treatment site. Restenosis is typically experienced by some patients within the first 6 months of treatment, which most often results in re-intervention or surgery.


NephroPath

Time to diagnosis can have a critical effect on the ultimate outcome of many renal diseases, and when a patient undergoes an invasive procedure such as a renal biopsy, there can be significant anxiety while the results are pending. Over the last 14 years, Dr. Patrick Walker, our Director and one of the nation's leading renal pathologists, has developed a unique system for rapid processing of renal...

U.S. Renal Care, Inc.

Founded in 2000 by an experienced team of healthcare executives, U.S. Renal Care, Inc. works in partnership with nephrologists to develop, acquire, and operate outpatient treatment centers for persons suffering from chronic kidney failure, also known as End Stage Renal Disease. The company provides patients with their choice of a full range of quality in-center, acute or at-home hemodialysis and p...


Frenova Renal Research

Frenova is the world’s only drug and medical device contract clinical development services provider dedicated exclusively to renal research. As a Fresenius Medical Care North America company, Frenova manages a networked system of clinical research assets and resources including over 450 principal investigators at more than 260 sites representing 160 m...

Advicenne

Advicenne (Euronext: ADVIC) is a pharmaceutical company developing pediatric-friendly therapeutics for the treatment of orphan renal and neurological diseases. The Company’s lead product is ADV7103 which has demonstrated positive results in a European pivotal phase 3 study in children and adults with distal Tubular Renal Acidosis (dTRA), is also being...

DaVita Clinical Research

Quality, Timely, Cost Effective Clinical TrialsTotal Renal Research, Inc. has changed its name to DaVita Clinical Research (DCR). A renal Phase I-IV clinical trial site and site management organization (SMO) headquartered in Minneapolis, MN. DCR specializes in renal trials and is recognized as a leader in clinical trials for drugs and devices.

Kona Medical, Inc.

Kona Medical is committed to alleviating the suffering and health risks associated with drug-resistant hypertension with a more effective, less invasive approach to renal artery denervation. The company was founded in 2009 by Michael Gertner, MD, with seed financing from Essex Woodlands. Kona was formed on the basis of combining Dr. Gertner’s inventio...

Foxhollow Technologies

An estimated 12 million people in the U.S. alone have peripheral arterial disease (PAD). At least 40% of them also suffer from coronary artery disease (CAD). FoxHollow recently launched the SilverHawk® Plaque Excision System, a device that removes the plaque that commonly blocks arteries and interrupts blood flow. Unlike stenting and other methods of opening the artery, the SilverHawk removes the...

American Renal Associates Holdings, Inc.

American Renal Associates Holdings, Inc. is the parent of American Renal Holdings, Inc. and American Renal Associates LLC (“ARA”) and is a leading owner and provider of outpatient kidney dialysis facilities operating facilities in partnership with nephrologists throughout the United States. The Company’s unique operating philosophy merges ph...

Arteriocyte, Inc.

Arteriocyte’s focus is the development of stem cell-based therapies to treat ischemia in patients suffering from coronary artery disease, peripheral vascular disease, stroke, and renal ischemia. The Company was founded in January of 2004 and is based upon more than 4 years of NIH sponsored research utilizing stem cells to stimulate angiogenesis (new vessel growth). Arteriocyte’s development pr...

Renal Ventures Management, LLC

Renal Ventures Management, LLC is a leading provider of dialysis services. The company partners with top physicians to provide patients with knowledgeable, compassionate and quality-focused care in comfortable clinic settings. For its nephrologist partners, Renal Ventures Management provides management expertise and patient-focused care operations which ce...

NxStage Medical

NxStage Medical is not your typical medical products company. We are a close-knit team of talented professionals driven by a shared commitment: to lead a movement to dramatically improve renal care with innovative yet simple therapeutic solutions that benefit patients, caregivers, and society. We pursue this goal through a passionate commitment to Innovate, Educate and Advocate for the breakthrou...

Pathway Medical Technologies Inc.

Pathway Medical Technologies, Inc. (Pathway), located in Redmond, Washington was founded in 1998 to design, develop and manufacture innovative medical devices intended for the treatment of arterial disease. The company’s initial focus is on peripheral artery disease (PAD).According to the American Heart Association, peripheral artery disease affects 8 – 12 million in the U.S. PAD prevalence in...

Renal Ventures Management LLC

Renal Ventures Management LLC is a leading provider of dialysis services in the U.S. The company partners with hospitals and physicians to provide patients suffering from chronic kidney failure with knowledgeable, compassionate and quality-focused care in comfortable clinic settings. For its hospital and nephrologist partners, Renal Ventures Management pro...

Diaverum

Diaverum ™ is a world leading provider of renal health care. The company has operations in 14 countries and provides treatment to around 16.000 patients. Diaverum differs from other providers through personalized in renal health care. For more information please visit our corporate website www.diaverum.com

American Renal Holdings

American Renal Associates LLC (“ARA”) is the operating subsidiary of American Renal Holdings, Inc. and is a leading owner and provider of outpatient kidney dialysis centers operating centers in partnership with nephrologists throughout the United States. The Company’s unique operating philosophy merges physician autonomy, leading edge patient ...

American Renal Associates LLC

American Renal Associates LLC (“ARA”) is the operating subsidiary of American Renal Holdings, Inc. and is a leading owner and provider of outpatient kidney dialysis facilities operating facilities in partnership with nephrologists throughout the United States. The Company’s unique operating philosophy merges physician autonomy, leading edge ...

Relevant

Healthy Life Screening

Located in Akron, Ohio, Healthy Life Screening was started in 2006 offering a range of preventive health screens on asymptomatic individuals for the presence of cardiovascular disease. The screening consists of five tests: left ventricle dysfunction, peripheral artery disease, abdominal aortic, carotid artery screening (including carotid intima-media thick...

Corthera Inc.

Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator. Elevated levels of relaxin modulate increases in renal and cardiac function that meet the increased hemodynamic demands of pregnancy. Consistent with this natural role of the hormone, pharmaceutically manufactured relaxin has been shown to have these effects in multiple human studies of men and non-preg...

About Renal Ventures Management, LLC

Renal Ventures Management LLC is a leading provider of dialysis services in the U.S. The company partners with hospitals and physicians to provide patients suffering from chronic kidney failure with knowledgeable, compassionate and quality-focused care in comfortable clinic settings. For its hospital and nephrologist partners, Renal Ventures Management pro...

PlaqueTec Ltd.

PlaqueTec offers a first-of-its-kind catheter technology for cardiologists to routinely assess inflammation in the coronary artery, and better understand residual inflammatory risk. It has been proven to detect inflammatory molecules across the site of coronary artery disease (CAD), and can discriminate between patients with greater and lesser levels of co...

Minnow Medical, Inc.

Minnow Medical is an innovative cardiovascular medical device company applying its extensive experience in cardiovascular biology, radiofrequency energy and tissue biology to the treatment of peripheral artery disease. The Company’s recently developed Z Cath™ System combines a balloon angioplasty catheter with non-ablative radio frequency energy ...

Intact Vascular

Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. This technology will offer physicians a new treatment option for treating peripheral ar...

Intact Vascular, Inc.

Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. This technology will offer physicians a new treatment paradigm for treating peripheral ...

Intact Vascular, LLC

Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. This technology will offer physicians a new treatment option for treating peripheral ar...


More From BioPortfolio on "Renal artery stenting atherosclerotic renal artery stenosis identified"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks